Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Share Price
Equities
300760
CNE100003G67
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 194.81 CNY | -1.12% |
|
-1.96% | -23.60% |
| Capitalization | 236B 33.46B 28.42B 26.58B 24.92B 45.99B 3,042B 50.4B 311B 120B 1,429B 125B 123B 5,180B | P/E ratio 2025 * |
24.6x | P/E ratio 2026 * | 20.6x |
|---|---|---|---|---|---|
| Enterprise value | 216B 30.61B 26B 24.32B 22.8B 42.08B 2,783B 46.12B 284B 110B 1,308B 115B 112B 4,739B | EV / Sales 2025 * |
6.28x | EV / Sales 2026 * | 5.38x |
| Free-Float |
42.59% | Yield 2025 * |
2.7% | Yield 2026 * | 3.12% |
| 1 day | -1.12% | ||
| 1 week | -1.96% | ||
| Current month | -4.51% | ||
| 1 month | -6.21% | ||
| 3 months | -18.69% | ||
| 6 months | -17.67% | ||
| Current year | -23.60% |
| 1 week | 194.51 |  | 200.75 |
| 1 month | 191.78 | | 207.25 |
| Current year | 191.78 | | 267.1 |
| 1 year | 191.78 | | 267.1 |
| 3 years | 191.78 | | 353 |
| 5 years | 191.78 | | 503.51 |
| 10 years | 58.56 | | 503.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Wu
CEO | Chief Executive Officer | 53 | 16/11/2020 |
Yun Zhao
DFI | Director of Finance/CFO | 42 | 14/11/2019 |
Yan Mei Guo
PRN | Corporate Officer/Principal | 62 | 26/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Hang Xu
CHM | Chairman | 63 | 24/01/1999 |
Xi Ting Li
CHM | Chairman | 74 | 17/12/2001 |
Ming He Cheng
BRD | Director/Board Member | 64 | 04/01/2017 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 6.79% | 0 M€ | -19.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.12% | -1.96% | -23.21% | -37.31% | 33.46B | |
| -1.00% | +1.26% | +7.52% | +6.29% | 214B | |
| -0.88% | -0.64% | +2.32% | +109.53% | 197B | |
| -1.68% | +0.66% | -4.05% | -14.25% | 159B | |
| +0.82% | +0.45% | +2.75% | +102.90% | 138B | |
| +0.57% | +1.39% | -17.42% | -7.67% | 58.08B | |
| +2.33% | +2.45% | +15.44% | +16.86% | 49.51B | |
| -1.00% | -1.03% | +1.10% | -6.77% | 39.4B | |
| -2.61% | -0.94% | +2.44% | +44.96% | 37.47B | |
| -2.26% | +0.33% | +2.62% | +17.89% | 36.05B | |
| Average | -0.80% | +0.24% | -1.05% | +23.24% | 96.13B | |
| Weighted average by Cap. | -0.74% | +0.42% | +1.05% | +37.45% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 34.33B 4.88B 4.14B 3.87B 3.63B 6.7B 443B 7.35B 45.25B 17.46B 208B 18.29B 17.91B 755B | 39.18B 5.56B 4.73B 4.42B 4.14B 7.65B 506B 8.38B 51.64B 19.92B 238B 20.87B 20.44B 861B |
| Net income | 9.59B 1.36B 1.16B 1.08B 1.01B 1.87B 124B 2.05B 12.64B 4.88B 58.17B 5.11B 5B 211B | 11.46B 1.63B 1.38B 1.29B 1.21B 2.24B 148B 2.45B 15.11B 5.83B 69.52B 6.11B 5.98B 252B |
| Net Debt | -20.03B -2.84B -2.42B -2.26B -2.12B -3.91B -259B -4.28B -26.4B -10.18B -121B -10.67B -10.45B -440B | -24.68B -3.51B -2.98B -2.79B -2.61B -4.82B -319B -5.28B -32.53B -12.55B -150B -13.15B -12.87B -543B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/12/25 | 194.81 ¥ | -1.12% | 5,151,933 |
| 15/12/25 | 197.01 ¥ | -1.41% | 4,945,501 |
| 12/12/25 | 199.82 ¥ | +2.07% | 11,203,340 |
| 11/12/25 | 195.77 ¥ | -1.13% | 5,672,846 |
| 10/12/25 | 198.00 ¥ | -0.36% | 5,134,463 |
End-of-day quote Shenzhen S.E., December 15, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300760 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition